Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration is the most common form of legal blindness in westernized societies, and polymorphisms in the gene encoding complement factor H ( CFH ) are associated with susceptibility to age-related macular degeneration in more than half of affected individuals. To investigate the relationship between complement factor H (CFH) and retinal disease, we performed functional and anatomical analysis in 2-year-old CFH-deficient ( cfh −/− ) mice. cfh −/− animals exhibited significantly reduced visual acuity and rod response amplitudes on electroretinography compared with age-matched controls. Retinal imaging by confocal scanning laser ophthalmoscopy revealed an increase in autofluorescent subretinal deposits in the cfh −/− mice, whereas the fundus and vasculature appeared normal. Examination of tissue sections showed an accumulation of complement C3 in the neural retina of the cfh −/− mice, together with a decrease in electron-dense material, thinning of Bruch's membrane, changes in the cellular distribution of retinal pigment epithelial cell organelles, and disorganization of rod photoreceptor outer segments. Collectively, these data show that, in the absence of any specific exogenous challenge to the innate immune system, CFH is critically required for the long-term functional health of the retina.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Funduscopic examination and vasculature, however, appears normal in the cfh−/− mice.”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Coffey et al., 2007
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“At age 2 years, cfh−/− mice exhibited significantly reduced visual acuity and rod response amplitudes on electroretinography as compared with age-matched control mice (Coffey et al., 2007).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Coffey et al., 2007
The cited source says what the claim attributes to it.
In the citing paper
“Melanosomes, lipofuscin granules, and melanosome-lipofuscin granules were dispersed throughout the RPE in cfh−/− mice, compared to primarily apical localization of organelles observed in controls (Coffey et al., 2007).”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Coffey et al., 2007
The cited source says what the claim attributes to it.
In the citing paper
“a cfh−/− mouse model was made and found to have poor visual function at two years of age (Coffey et al., 2007).”
From Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD) (2010) · cites this paper as Coffey et al., 2007
In the citing paper
“These mice also demonstrated increased autofluorescence, accumulation of C3, and disorganization of photoreceptor outer segments in the retina, as well as thinning of Bruch’s membrane and increased RPE organelles.”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Coffey et al., 2007
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Complement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Walport, M. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104053441406 · Cited by 2,927
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449
Complement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424
Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961
Walport, M. J. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104123441506 · Cited by 1,481
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265
Drusen proteome analysis: an approach to the etiology of age-related macular degeneration
Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222551899 · Cited by 1,208
A role for local inflammation in the formation of drusen in the aging eye
Anderson, D. H., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01624-0 · Cited by 1,087
The AMD Genetics Clinical Study Group, Gold, B., Merriam, J. E., Zernant, J., Hancox, L. S., Taiber, A. J., Gehrs, K., Cramer, K., Neel, J., Bergeron, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1750 · Cited by 1,075
Research works printed but not linked: 4
- Chen J, Fitzke F, Pauliekhoff D, Bird AC. Invest Ophthalmol Visual Sci. 1992;33:334–340. [PubMed] [Google Scholar]
- Curcio CA, Medeiros NE, Millican CL. Invest Ophthalmol Visual Sci. 1996;37:1236–1249. [PubMed] [Google Scholar]
- Von Ruckmann A, Fitzke FW, Bird AC. Invest Ophthalmol Visual Sci. 1997;38:478–486. [PubMed] [Google Scholar]
- Lewis GP, Linberg KA, Fisher SK. Invest Ophthalmol Visual Sci. 1998;39:424–434. [PubMed] [Google Scholar]
Cited by
Molecular pathology of age-related macular degeneration
Ding, X., Patel, M., & Chan, C.-C. (2009) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.10.001 · Cited by 582
“At age 2 years, cfh−/− mice exhibited significantly reduced visual acuity and rod response amplitudes on electroretinography as compared with age-matched control mice (Coffey et al., 2007).”
BackgroundLiao, D. S., Grossi, F. V., El Mehdi, D., Gerber, M. R., Brown, D. M., Heier, J. S., Wykoff, C. C., Singerman, L. J., Abraham, P., Grassmann, F., et al. (2020) · Ophthalmology · doi:10.1016/j.ophtha.2019.07.011 · Cited by 519
Animal models of age related macular degeneration
Pennesi, M. E., Neuringer, M., & Courtney, R. J. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.06.003 · Cited by 391
Parker, A., Romano, S., Ansorge, R., Aboelnour, A., Le Gall, G., Savva, G. M., Pontifex, M. G., Telatin, A., Baker, D., Jones, E., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01243-w · Cited by 368
“Polymorphisms in human complement regulatory factor H (CFH) predispose individuals to AMD [35, 46, 59] and CFH deficiency in mice causes retinal abnormalities, including accumulation of complement C3, resulting in significant visual dysfunction [28].”
BackgroundRPE necroptosis in response to oxidative stress and in AMD
Hanus, J., Anderson, C., & Wang, S. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.09.002 · Cited by 286
Dry Age-Related Macular Degeneration: Mechanisms, Therapeutic Targets, and Imaging
Bowes Rickman, C., Farsiu, S., Toth, C. A., & Klingeborn, M. (2013) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-12757 · Cited by 282
“This is supported by the ocular phenotype in CFH knock-out mice, generated to model factor H deficiency in humans,(80) which revealed that old CFH knock-out animals exhibit an age-related decrease in visual acuity (VA) with evidence of C3 deposition.(81) CFH, which is implicated as the strongest genetic risk factor fo…”
Swaroop, A., Chew, E. Y., Bowes Rickman, C., & Abecasis, G. R. (2009) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.9.081307.164350 · Cited by 270
“The Cfh−/− mice exhibit an agerelated decrease in visual acuity and impaired photoreceptor function with evidence of C3 deposition and ultrastructural changes in the retina, but less basal membrane thickening and less sub-RPE drusen-like material compared with age-matched wild-type controls (28).”
Boyer, D. S., Schmidt-Erfurth, U., van Lookeren Campagne, M., Henry, E. C., & Brittain, C. (2017) · Retina · doi:10.1097/iae.0000000000001392 · Cited by 258
Factor H family proteins and human diseases
Józsi, M., & Zipfel, P. F. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.04.008 · Cited by 254
A new perspective on lipid research in age-related macular degeneration
van Leeuwen, E. M., Emri, E., Merle, B. M. J., Colijn, J. M., Kersten, E., Cougnard-Gregoire, A., Dammeier, S., Meester-Smoor, M., Pool, F. M., de Jong, E. K., et al. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2018.04.006 · Cited by 247
“Complement factor H knockout (Cfh−/−) animals showed a thinning of Bruch's membrane (Coffey et al., 2007) when the animals were raised on normal chow.”
BackgroundSelf-citationAge related macular degeneration and drusen: Neuroinflammation in the retina
Buschini, E., Piras, A., Nuzzi, R., & Vercelli, A. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.05.011 · Cited by 230
A comparison of some organizational characteristics of the mouse central retina and the human macula
Volland, S., Esteve-Rudd, J., Hoo, J., Yee, C., & Williams, D. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0125631 · Cited by 229
The “Neuro-Glial-Vascular” Unit: The Role of Glia in Neurovascular Unit Formation and Dysfunction
Kugler, E. C., Greenwood, J., & MacDonald, R. B. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.732820 · Cited by 209
Self-citationLuhmann, U. F. O., Robbie, S., Munro, P. M. G., Barker, S. E., Duran, Y., Luong, V., Fitzke, F. W., Bainbridge, J. W. B., Ali, R. R., & MacLaren, R. E. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-3462 · Cited by 205
Self-citationOn phagocytes and macular degeneration
Guillonneau, X., Eandi, C. M., Paques, M., Sahel, J.-A., Sapieha, P., & Sennlaub, F. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.06.002 · Cited by 185
“…to its previously described decreased capacity to (i) inhibit oxidative stress (Shaw et al., 2012; Weismann et al., 2011), and (ii) to bind to Bruchs membrane (Clark et al., 2010), which might protect the RPE against uncontrolled complement activation (Coffey et al., 2007; Toomey et al., 2015).”
BackgroundGeographic Atrophy: A Histopathological Assessment
Bird, A. C., Phillips, R. L., & Hageman, G. S. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2013.5799 · Cited by 195
Self-citationImmune mechanisms in inflammatory and degenerative eye disease
Perez, V. L., & Caspi, R. R. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.04.003 · Cited by 188
Oxidative Stress Renders Retinal Pigment Epithelial Cells Susceptible to Complement-mediated Injury
Thurman, J. M., Renner, B., Kunchithapautham, K., Ferreira, V. P., Pangburn, M. K., Ablonczy, Z., Tomlinson, S., Holers, V. M., & Rohrer, B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808166200 · Cited by 185
Begum, R., Powner, M. B., Hudson, N., Hogg, C., & Jeffery, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057828 · Cited by 179
Complement Factor H Inhibits CD47-Mediated Resolution of Inflammation
Calippe, B., Augustin, S., Beguier, F., Charles-Messance, H., Poupel, L., Conart, J.-B., Hu, S. J., Lavalette, S., Fauvet, A., Rayes, J., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.01.006 · Cited by 168
“, 2010) that protects the RPE against uncontrolled complement activation (Coffey et al., 2007; Toomey et al., 2015).”
BackgroundSelf-citationTherapeutic targets in age-related macular disease
Bird, A. C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42437 · Cited by 175
Self-citationAge-related macular degeneration and the complement system
Khandhadia, S., Cipriani, V., Yates, J. R. W., & Lotery, A. J. (2012) · Immunobiology · doi:10.1016/j.imbio.2011.07.019 · Cited by 167
Abokyi, S., To, C.-H., Lam, T. T., & Tse, D. Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7901270 · Cited by 167
“CFH knockout mice have decreased plasma C3 concentration, unlike CFH polymorphisms which do not present with changes in C3 levels [151].”
BackgroundImmunopathological aspects of age-related macular degeneration
Patel, M., & Chan, C.-C. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0112-9 · Cited by 164
“proposed that cfh might itself be a major component or activator of drusen biogenesis and, thus, its absence might impair drusen biogenesis [52].”
BackgroundKunchithapautham, K., Atkinson, C., & Rohrer, B. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.564674 · Cited by 163
“Dysregulation of the complement system in mouse on the other hand has been associated with changes in retinal structure and function (63, 64), alterations in retinal perfusion (65); but no data are available on UPR or lipid dysregulation in that context.”
BackgroundRetinal ultrastructure of murine models of dry age-related macular degeneration (AMD)
Ramkumar, H. L., Zhang, J., & Chan, C.-C. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.02.002 · Cited by 163
“[PubMed: 15944936] Chang B, Dacey MS, Hawes NL, Hitchcock PF, Milam AH, Atmaca-Sonmez P, Nusinowitz S, Heckenlively JR. Cone Photoreceptor Function Loss-3, a Novel Mouse Model of Achromotopsia Due to a Mutation in Gnat2.”
BackgroundInfluentialComplement factor H in AMD: Bridging genetic associations and pathobiology
Toomey, C. B., Johnson, L. V., & Bowes Rickman, C. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.09.001 · Cited by 161
“…groups have studied the combined effect of aging and complement deficiency on ocular phenotype in mouse models, attempting to link the age-associated risk of AMD with complement dysregulation (Coffey et al., 2007; Ding et al., 2015; Hoh Kam et al., 2013; Hoh Kam et al., 2016; Toomey et al., 2015).”
BackgroundInfluentialRohrer, B., Long, Q., Coughlin, B., Wilson, R. B., Huang, Y., Qiao, F., Tang, P. H., Kunchithapautham, K., Gilkeson, G. S., & Tomlinson, S. (2009) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.08-2222 · Cited by 154
“Of note, fH deficiency results in retinal abnormalities and vision dysfunction in aged mice, and while these studies suggest that there is no requirement for an additional trigger for complement-dependent retinal disease, fH-deficient mice do not develop vasculature changes.(36) It should also be noted that fH-deficie…”
BackgroundSchmitz-Valckenberg, S., Steinberg, J. S., Fleckenstein, M., Visvalingam, S., Brinkmann, C. K., & Holz, F. G. (2010) · Ophthalmology · doi:10.1016/j.ophtha.2009.10.044 · Cited by 166
Regulation of age-related macular degeneration-like pathology by complement factor H
Toomey, C. B., Kelly, U., Saban, D. R., & Bowes Rickman, C. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424391112 · Cited by 154
“Scotopic ERGs were recorded using an Espion E2 system (Diagnosys), at increasing flash intensities.”
BackgroundMethodInfluentialSchnichels, S., Paquet‐Durand, F., Löscher, M., Tsai, T., Hurst, J., Joachim, S. C., & Klettner, A. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100880 · Cited by 162
Oxidative Stress and Antioxidants in Age-Related Macular Degeneration
Kushwah, N. S., Bora, K., Maurya, M., Pavlovich, M. C., & Chen, J. (2023) · Antioxidants · doi:10.3390/antiox12071379 · Cited by 163
Feigl, B. (2008) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2008.11.004 · Cited by 149
“Coffey et al. (2007) demonstrated a reduction in rod photoreceptor function in CFH deficient mice by the use of the fullfield electroretinogram.”
MethodChen, H., Liu, B., Lukas, T. J., & Neufeld, A. H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002339 · Cited by 129
“In addition, knockout of CFH in mice causes AMD-like changes when the animals age [39].”
BackgroundC3- and CR3-dependent microglial clearance protects photoreceptors in retinitis pigmentosa
Silverman, S. M., Ma, W., Wang, X., Zhao, L., & Wong, W. T. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20190009 · Cited by 119
“In the retina, absent any induced injury, long-term genetic ablation of complement molecules has resulted in a slow deterioration of structure and function that gradually becomes evident in aged animals (Coffey et al., 2007; Yu et al., 2012; Hoh Kam et al., 2013; Mukai et al., 2018), indicating that constitutive compl…”
BackgroundCopy number variation influences gene expression and metabolic traits in mice
Orozco, L. D., Cokus, S. J., Ghazalpour, A., Ingram-Drake, L. A., Wang, S. S.-M., van Nas, A., Che, N., Araujo, J. A., Pellegrini, M. A., & Lusis, A. J. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp360 · Cited by 124
Animal Models of Retinal Disease
Fletcher, E. L., Jobling, A. I., Vessey, K. A., Luu, C. D., Guymer, R. H., & Baird, P. N. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-384878-9.00006-6 · Cited by 120
“Moreover, lack of CFH in mice was associated with a phenotype quite distinct to those with a high risk CFH polymorphism.(210)”
BackgroundInfluentialCell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases
Jones, M. K., Lü, B., Girman, S., & Wang, S. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.01.004 · Cited by 125
“For AMD, one of the first gene mutations discovered in humans was in the complement factor H (CFH) gene, and the Cfh−/− mouse has similar disease features including loss of photoreceptors, reduced rod function, and complement deposits; however, these animals also experience complications with glomerulonephritis and ca…”
BackgroundTransgenic Mice Expressing Variants of Complement Factor H Develop AMD-like Retinal Findings
Ufret-Vincenty, R. L., Aredo, B., Liu, X., McMahon, A., Chen, P. W., Sun, H., Niederkorn, J. Y., & Kedzierski, W. (2010) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.09-4457 · Cited by 104
“The absence of basal laminar deposits and wide-banded collagen in our B6 and mCfhKO mice was consistent with findings by several other groups in B6 mice younger than 16 months of age and on a normal diet and in 2-year-old mCfhKO mice.(34) We performed immunostaining in our paraffin-embedded tissue looking for C3d depo…”
ResultZeiss, C. J. (2010) · Veterinary Pathology · doi:10.1177/0300985809359598 · Cited by 102
“Animals that survive to 2 years develop mild loss of photoreceptors, reduced rod function, and increased deposition of complement in the photoreceptor layer.(14) Zeiss 401”
BackgroundZhang, H., Fan, J., Li, S., Karan, S., Rohrer, B., Palczewski, K., Frederick, J. M., Crouch, R. K., & Baehr, W. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0317-08.2008 · Cited by 101
Ao, J., Wood, J. P. M., Chidlow, G., Gillies, M. C., & Casson, R. J. (2018) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.13121 · Cited by 112
“Increasing expression of human CFH in this model resulted in the inhibition of AP complement pathway, reduction of sub-RPE deposits as well as prevention of retinal and kidney damage caused by CFH deletion in a dosedependent manner.(140,141) The process of APmediated RPE cell death which occurs in GA involves lysis of…”
BackgroundChen, M., Muckersie, E., Robertson, M., Forrester, J. V., & Xu, H. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.09.005 · Cited by 99
Natoli, R., Fernando, N., Jiao, H., Racic, T., Madigan, M., Barnett, N. L., Chu-Tan, J. A., Valter, K., Provis, J., & Rutar, M. (2017) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.17-21672 · Cited by 97
Kenney, M. C., Chwa, M., Atilano, S. R., Pavlis, J. M., Falatoonzadeh, P., Ramirez, C., Malik, D., Hsu, T., Woo, G., Soe, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054339 · Cited by 96
“Using animal models, it has been shown that CFH is critical for longterm retinal function [46].”
MethodMouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss
Collin, G. B., Gogna, N., Chang, B., Damkham, N., Pinkney, J., Hyde, L. F., Stone, L. V., Naggert, J. Κ., Nishina, P. M., & Krebs, M. P. (2020) · Cells · doi:10.3390/cells9040931 · Cited by 106
“Cfhtm1Mbo was shown to have an impairment of rod and cone function by ERG and 29% decreased thickness of Bruch’s membrane; however, rod opsin was distributed normally and no significant reduction in the number of PR cells was observed [432].”
BackgroundStudying Age-Related Macular Degeneration Using Animal Models
Fletcher, E. L., Jobling, A. I., Greferath, U., Mills, S. A., Waugh, M., Ho, T., de Iongh, R. U., Phipps, J. A., & Vessey, K. A. (2014) · Optometry and Vision Science · doi:10.1097/opx.0000000000000322 · Cited by 93
“numerous autofluorescent lesions at the base of the RPE, and increased C3 deposition with age.(40,41) However, they do not develop deposits below the RPE or thickening of the Bruch membrane.”
BackgroundPerspectives on reticular pseudodrusen in age-related macular degeneration
Sivaprasad, S., Bird, A. C., Nitiahpapand, R., Nicholson, L., Hykin, P., & Chatziralli, I. (2016) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2016.02.005 · Cited by 95
Self-citationDevelopments in anti-complement therapy; from disease to clinical trial
Harris, C. L., Pouw, R. B., Kavanagh, D., Sun, R., & Ricklin, D. (2018) · Molecular Immunology · doi:10.1016/j.molimm.2018.06.008 · Cited by 91
Photoreceptor Layer Thinning Is an Early Biomarker for Age-Related Macular Degeneration
Zekavat, S. M., Sekimitsu, S., Ye, Y., Raghu, V. K., Zhao, H., Elze, T., Segrè, A. V., Wiggs, J. L., Natarajan, P., Priore, L. V. D., et al. (2022) · Ophthalmology · doi:10.1016/j.ophtha.2022.02.001 · Cited by 92
Targeting complement components C3 and C5 for the retina: Key concepts and lingering questions
Kim, B. J., Mastellos, D. C., Li, Y., Dunaief, J. L., & Lambris, J. D. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100936 · Cited by 88
Charbel Issa, P., Victor Chong, N., & Scholl, H. P. N. (2011) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-010-1568-6 · Cited by 87
“A CFH-/- mouse model has been described which develops a retinal phenotype in old age [60].”
BackgroundKam, J. H., Lenassi, E., Malik, T. H., Pickering, M. C., & Jeffery, G. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.04.008 · Cited by 87
Self-citationHsp90 inhibition protects against inherited retinal degeneration
Aguilà, M., Bevilacqua, D., McCulley, C. H., Schwarz, N., Athanasiou, D., Kanuga, N., Novoselov, S. S., Lange, C., Ali, R. R., Bainbridge, J. W., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt613 · Cited by 91
Self-citationComplementing the sugar code: Role of GAGs and sialic acid in complement regulation
Langford-Smith, A., Day, A. J., Bishop, P. N., & Clark, S. J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00025 · Cited by 80
“One particular variant of FH/FHL-1 (termed 402H; that has a histidine at residue 402 in CCP7) is associated with an increased risk of age-related macular degeneration (AMD), a common cause of blindness in developed nations, and requires a high level of HS sulfation for its binding (23, 24).”
BackgroundInfluentialEnzbrenner, A., Zulliger, R., Biber, J., Pousa, A. M. Q., Schäfer, N., Stucki, C., Giroud, N., Berrera, M., Körtvely, E., Schmucki, R., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179218 · Cited by 86
“Single nucleotide polymorphisms in the CFH gene are associated with an increased risk for AMD, and studies with cfh−/− mice have shown a pathological accumulation of debris in CFH-deficient RPE cells [26,28].”
BackgroundAvasthi, P., Watt, C. B., Williams, D. S., Le, Y. Z., Li, S., Chen, C.-K., Marc, R. E., Frederick, J. M., & Baehr, W. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3976-09.2009 · Cited by 77
“…(LRAT) (Zhang et al., 2008), the cone CNG channel -subunit (CNGA3) (Michalakis et al., 2005), BBS4 (Abd-El-Barr et al., 2007), and complement factor H (Coffey et al., 2007), suggesting that vesicular and intraflagellar transport in cones is dependent on a number of gene products/cofactors.”
BackgroundLoss of chromatic sensitivity in AMD and diabetes: a comparative study
O’Neill‐Biba, M., Sivaprasad, S., Rodriguez‐Carmona, M., Wolf, J. E., & Barbur, J. L. (2010) · Ophthalmic and Physiological Optics · doi:10.1111/j.1475-1313.2010.00775.x · Cited by 74
“This observation is consistent with findings from a study which showed that complement factor H deficient mice showed significant reduction in retinal function as revealed using electroretinography techniques (Coffey et al., 2007).”
ResultImplications of genetic variation in the complement system in age-related macular degeneration
de Jong, S., Gagliardi, G., Garanto, A., de Breuk, A., Lechanteur, Y. T. E., Katti, S., van den Heuvel, L. P., Volokhina, E. B., & den Hollander, A. I. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.100952 · Cited by 71
“the neuroretina and significantly reduced electroretinographic amplitudes (Coffey et al., 2007).”
BackgroundThe role of complement in ocular pathology
Bora, N. S., Jha, P., & Bora, P. S. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0110-y · Cited by 67
“, photoreceptor dysfunction, increased deposition of C3 in retina, thinning of Bruch’s membrane) which is consistent with those seen in AMD [83].”
ResultSialylation acts as a checkpoint for innate immune responses in the central nervous system
Klaus, C., Liao, H., Allendorf, D. H., Brown, G. C., & Neumann, H. (2021) · Glia · doi:10.1002/glia.23945 · Cited by 67
“…of Bruch's membrane, changes in the cellular distribution of retinal pigment epithelial cell organelles, and disorganization of rod photoreceptor outer segments (Coffey et al., 2007), but it is unclear how far this effect is related to Siabinding of FH (Toomey, Kelly, Saban, & Bowes Rickman, 2015).”
BackgroundA CTRP5 gene S163R mutation knock-in mouse model for late-onset retinal degeneration
Chavali, V. R. M., Khan, N. W., Cukras, C. A., Bartsch, D., Jablonski, M. M., & Ayyagari, R. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr080 · Cited by 71
“The ERG response of the Cfh gene knock-out model also showed compromised rod photoreceptor function with minimal changes in cone function (42).”
BackgroundShiose, S., Chen, Y., Okano, K., Roy, S., Kohno, H., Tang, J., Pearlman, E., Maeda, T., Palczewski, K., & Maeda, A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.228551 · Cited by 65
Ding, J.-D., Kelly, U., Landowski, M., Toomey, C. B., Groelle, M., Miller, C., Smith, S. G., Klingeborn, M., Singhapricha, T., Jiang, H., et al. (2015) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.08.026 · Cited by 64
Maurya, M., Bora, K., Blomfield, A. K., Pavlovich, M. C., Huang, S., Liu, C.-H., & Chen, J. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.369098 · Cited by 63
“These include inflammation ( Cfh –/– and/or Cx3cr1 –/– mice) (Coffey et al., 2007; Combadiere et al., 2007), impaired lipid function (transgenic ApoE4 with high-fat diet, and macrophage-specific ABCA1 and ABCG1 deficiency) (Ramkumar et al., 2010; Ban et al., 2018), and oxidative stress and defense…”
Bennis, A., Gorgels, T. G. M. F., ten Brink, J. B., van der Spek, P. J., Bossers, K., Heine, V. M., & Bergen, A. A. B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141597 · Cited by 65
Langford-Smith, A., Keenan, T. D. L., Clark, S. J., Bishop, P. N., & Day, A. J. (2014) · Journal of Innate Immunity · doi:10.1159/000356513 · Cited by 62
Progress in developing rodent models of age-related macular degeneration (AMD)
Pandi, S. P. S., Ratnayaka, J. A., Lotery, A. J., & Teeling, J. L. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108404 · Cited by 66
Different Therapeutic Approaches for Dry and Wet AMD
Marchesi, N., Capierri, M., Pascale, A., & Barbieri, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252313053 · Cited by 72
Kopplin, L. J., Igo, R. P., Wang, Y., Sivakumaran, T. A., Hagstrom, S. A., Peachey, N. S., Francis, P. J., Klein, M. L., SanGiovanni, J. P., Chew, E. Y., et al. (2010) · Genes and Immunity · doi:10.1038/gene.2010.39 · Cited by 72
“…functions have been ascribed to CFH , but an underappreciated and recent discovery is that CFH has a role in proper distribution of melanosomes.26 CFH deficiency in aged knockout mice shows that there are changes in the distribution of melanosomes, melanosome-lipofuscin and lipofuscin…”
InfluentialParfitt, D. A., Aguila, M., McCulley, C. H., Bevilacqua, D., Mendes, H. F., Athanasiou, D., Novoselov, S. S., Kanuga, N., Munro, P. M., Coffey, P. J., et al. (2014) · Cell Death & Disease · doi:10.1038/cddis.2014.214 · Cited by 59
“Scoptopic ERG was performed as previously described.(20,58) Briefly, animals were dark-adapted overnight before being anaesthetised via ketamine/xylazine i.”
MethodSelf-citationComplement dysregulation in AMD: RPE-Bruch’s membrane-choroid
Sparrow, J. R., Ueda, K., & Zhou, J. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.03.007 · Cited by 57
“For instance, mice with a null deletion in CFH exhibit photoreceptor cell degeneration and C3 deposition in association with RPE and photoreceptor outer segments but surprisingly, Bruch’s membrane is thinner than in wildtype mice (Coffey et al., 2007).”
BackgroundSynthesis and Propagation of Complement C3 by Microglia/Monocytes in the Aging Retina
Rutar, M., Valter, K., Natoli, R., & Provis, J. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093343 · Cited by 56
“Such degeneration may be accelerated by the ablation of CFH, which spurs increased deposition of C3 in the outer retina of aged mice, as well as reduced retinal function [55].”
BackgroundGenomic aspects of age-related macular degeneration
Horie‐Inoue, K., & Inoue, S. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.08.013 · Cited by 61
Bonilha, V. L., Bell, B. A., Rayborn, M. E., Yang, X., Kaul, C., Grossman, G. H., Samuels, I. S., Hollyfield, J. G., Xie, C., Cai, H., et al. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.07.014 · Cited by 56
“This extracellular meshwork is a dynamic structure that undergoes modeling of its structure and cellular components during aging and in pathological conditions (Killingsworth et al., 1990, Pauleikhoff et al., 1990, Okubo et al., 1999, Zarbin, 2004, Coffey et al., 2007).”
BackgroundNan, R., Gor, J., Lengyel, I., & Perkins, S. J. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.10.030 · Cited by 64
Ebeling, M. C., Geng, Z., Kapphahn, R. J., Roehrich, H., Montezuma, S. R., Dutton, J. R., & Ferrington, D. A. (2021) · Cells · doi:10.3390/cells10040789 · Cited by 51
“Young Cfh−/− mice have significantly disrupted and delayed retinal development [42] and aged Cfh−/− mice have decreased visual acuity compared to age-matched control mice [43].”
BackgroundComplement Factor H Is Critical in the Maintenance of Retinal Perfusion
von Leithner, P. L., Kam, J. H., Bainbridge, J. W., Catchpole, I. R., Gough, G., Coffey, P. J., & Jeffery, G. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080927 · Cited by 57
Self-citationModels of retinal diseases and their applicability in drug discovery
Malek, G., Busik, J. V., Grant, M. B., & Choudhary, M. (2018) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2018.1430136 · Cited by 55
Expression of Complement Component 3 (C3) from an Adenovirus Leads to Pathology in the Murine Retina
Cashman, S. M., Desai, A., Ramo, K., & Kumar-Singh, R. (2011) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.10-6002 · Cited by 51
McClelland, K. S., Bell, K. M., Larney, C., Harley, V. R., Sinclair, A. H., Oshlack, A., Koopman, P. A., & Bowles, J. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.115.128918 · Cited by 74
“ENSMUSG00000026365 Cfh Complement component factor h 1 No lethal developmental defects; fertile 126700/609814/235400/610698 [90, 91]”
BackgroundPujol-Lereis, L. M., Schäfer, N., Kuhn, L. B., Rohrer, B., & Pauly, D. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-17121-0_13 · Cited by 54
Bora, N. S., Matta, B., Lyzogubov, V. V., & Bora, P. S. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.07.012 · Cited by 52
Landowski, M., & Rickman, C. B. (2022) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2021.0067 · Cited by 48
“significance of impaired CFH binding to lipoproteins in vivo, C57BL/6J, Cfh heterozygous (Cfh), and Cfh mice were aged to ninety weeks and then fed a HFC diet for 8 weeks to exacerbate the subtle AMD-like phenotype seen in aged Cfh mice.(21,108,109) Consumption of a HFC diet leads to increased circulating lipoproteins…”
MethodLi, Y., Song, D., Song, Y., Zhao, L., Wolkow, N., Tobias, J. W., Song, W., & Dunaief, J. L. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.645903 · Cited by 51
“Both Factor B and Factor H are expressed by the RPE cell (15, 17, 18).”
BackgroundAngiogenesis in eye disease: immunity gained or immunity lost?
Ferguson, T. A., & Apte, R. S. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0113-8 · Cited by 47
“These mice do have some functional abnormalities of the retina but no signs of AMD [72].”
BackgroundLyzogubov, V. V., Bora, P. S., Wu, X., Horn, L. E., de Roque, R., Rudolf, X. V., Atkinson, J. P., & Bora, N. S. (2016) · The American Journal of Pathology · doi:10.1016/j.ajpath.2016.03.021 · Cited by 45
“completely inactive secondary to the fluid phase AP turnover.(51,88) Both FH (plasma protein) and CD46 (membrane bound protein) are regulators of the AP.”
BackgroundInfluentialSkerka, C., Licht, C. P. B., Mengel, M., Uzonyi, B., Strobel, S., Zipfel, P. F., & Józsi, M. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.05.018 · Cited by 45
Calaza, K. D. C., Kam, J. H., Hogg, C. R., & Jeffery, G. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.06.010 · Cited by 45
“The Cfh / mouse has been proposed as an AMDmodel (Coffey et al., 2007), and although it shares similarities of genotype and potential immune vulnerability with around 50% of AMD cases (Zipfel et al.”
A Family Affair: Addressing the Challenges of Factor H and the Related Proteins
Poppelaars, F., de Jorge, E. G., Jongerius, I., Baeumner, A. J., Steiner, M., Józsi, M., Toonen, E. J. M., & Pauly, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.660194 · Cited by 56
Zhang, Y., Huang, J., Liang, Y., Huang, J., Fu, Y., Chen, N., Lu, B., & Zhao, C. (2023) · Autophagy · doi:10.1080/15548627.2023.2220540 · Cited by 48
Amyloidosis in Retinal Neurodegenerative Diseases
Masuzzo, A., Dinet, V., Cavanagh, C., Mascarelli, F., & Krantic, S. M. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00127 · Cited by 51
Armento, A., Schmidt, T. L., Sonntag, I., Merle, D. A., Jarboui, M. A., Kilger, E., Clark, S. J., & Ueffing, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168727 · Cited by 49
“Indeed, cfh−/− mice, which show signs of retinal degeneration similar to AMD pathology, present higher levels of complement activation and inflammation [38].”
BackgroundEmerging therapies and their delivery for treating age‐related macular degeneration
Thomas, C. N., Sim, D. A., Lee, W. H., Alfahad, N., Dick, A. D., Denniston, A. K., & Hill, L. J. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15459 · Cited by 49
“…enriched diet spontaneously develop AMD-like retinal phenotypes, such as photoreceptor dysfunction, C3 depositions and Bruch's membrane thinning (Coffey et al., 2007). injection every 4 weeks will reduce the GA area growth over 12 months (Jaffe, Sahni, et al., 2020), with results expected in…”
BackgroundInteraction of Complement Factor H and Fibulin3 in Age-Related Macular Degeneration
Wyatt, M. K., Tsai, J.-Y., Mishra, S., Campos, M., Jaworski, C., Fariss, R. N., Bernstein, S. L., & Wistow, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068088 · Cited by 41
“Two-year old CFH null mice exhibit retinal and RPE problems, suggesting that loss of this regulatory protein can damage the eye [33], although the defects in these mice do not closely resemble AMD.”
BackgroundAge-Related Macular Degeneration: A Disease of Systemic or Local Complement Dysregulation?
Warwick, A., Khandhadia, S., Ennis, S., & Lotery, A. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041234 · Cited by 41
“For example, CFH−/− mice show significantly reduced electroretinogram responses, increased subretinal fluorescent material, and disruption of RPE and photoreceptor cells, suggesting a protective role for CFH [20].”
Death by color: differential cone loss in the aging mouse retina
Cunea, A., Powner, M. B., & Jeffery, G. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.012 · Cited by 43
“Elevated in fl ammation is also a key feature in the CFH (cid:1) / (cid:1) mice (Coffey et al., 2007).”
InfluentialAredo, B., Li, T., Chen, X., Zhang, K., Wang, C. X.-Z., Gou, D., Zhao, B., He, Y.-G., & Ufret-Vincenty, R. L. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.14-16089 · Cited by 42
The AKT2/SIRT5/TFEB pathway as a potential therapeutic target in non-neovascular AMD
Ghosh, S., Sharma, R., Bammidi, S., Koontz, V., Nemani, M., Yazdankhah, M., Kedziora, K. M., Stolz, D. B., Wallace, C. T., Yu-Wei, C., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50500-z · Cited by 44
“Conversely, while cfh − / − ( CFH null) mice also manifest decreased visual acuity compared to age-matched controls and develop C3 accumulation in the RPE, they did not show autophagy/lysosomal dysfunc-tionorvisiblephotoreceptororRPEdegenerationdespiteagingmice for up to 24 months 49 .”
Juel, H. B., Kæstel, C. G., Folkersen, L., Faber, C., Heegaard, N. H. H., Borup, R., & Nissen, M. H. (2011) · Experimental Eye Research · doi:10.1016/j.exer.2011.01.003 · Cited by 41
Metadata
- Authors
- Coffey, P. J., Gias, C., McDermott, C. J., Lundh, P., Pickering, M. C., Sethi, C., Bird, A., Fitzke, F. W., Maass, A., Chen, L. L., Holder, G. E., Luthert, P. J., Salt, T. E., Moss, S. E., & Greenwood, J.
- Affiliations
- University College London (GB)
- Johns Hopkins University (US)
- Pathology,
- Visual Science, and
- Imperial College London (GB)
- Moorfields Eye Hospital (GB)
- Corresponding author
- Greenwood, John
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2007-10-16
- Volume
- 104
- Issue
- 42
- Pages
- 16651-16656
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2034255
- OpenAlex
- W2121723196
- Cited by
- 231
- References
- 38
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 12 · 2023: 9 · 2022: 14 · 2021: 19 · 2020: 12 · 2019: 8 · 2018: 9 · 2017: 8 · 2016: 14 · 2015: 19 · 2014: 16 · 2013: 16 · 2012: 9
- FWCI
- 12.85
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Keywords
- complement factor H, age-related macular degeneration, retinal degeneration, visual acuity, electroretinogram, rod photoreceptors, complement C3, retinal pigment epithelium, Bruch's membrane, subretinal deposits, complement system, innate immunity
- MeSH terms
- Aging, Animals, Complement C3, Fluorescence, Immunity, Innate, Mice, Mutant Strains, Retina, Vision Disorders, Complement Factor H, Retinal Rod Photoreceptor Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.